CJC-1295 No DAC Vial

CJC-1295 No DAC is a short-acting analogue of growth hormone–releasing hormone (GHRH). In research environments, it is used as a model compound in studies involving GHRH receptor signalling, peptide interaction systems, and controlled experimental frameworks. Unlike DAC-modified variants, the No DAC form is characterised by its shorter duration profile, making it suitable for laboratory models examining time-dependent signalling patterns.

Chemical reference information: CAS number: 863288-34-0; Molecular formula: C₁₅₂H₂₅₂N₄₄O₄₂; Molecular weight: 3367.9 g/mol. These reference identifiers describe the formulation; the batch-specific analytical record identifies the supplied material.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

CJC-1295 No DAC 5 mg is offered as a NORVEXA research vial. The selected strength refers to the compound content of this vial reference. Request the matching batch record for identity, analytical specifications, and presentation details.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

CAS number

863288-34-0

Molecular formula

C₁₅₂H₂₅₂N₄₄O₄₂

Molecular weight

3367.9 g/mol

Include the printed batch reference when requesting your certificate of analysis. The record applies to the batch supplied to your laboratory.